Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Merial was a global, innovation-driven animal health company that provided a comprehensive range of products to enhance the health, well-being, and performance of a wide range of animal species, including companion animals, production animals (like cattle and swine), and avian species. Its portfolio included vaccines, parasiticides, and other pharmaceutical products. Merial was formed in 1997 as a joint venture between Merck & Co. (MSD Animal Health) and Sanofi-Aventis (Rhône Mérieux). In January 2017, Merial was acquired by Boehringer Ingelheim and its operations were integrated into Boehringer Ingelheim's Animal Health business unit, making Boehringer Ingelheim the second-largest animal health business globally.
Served as the central hub for global operations, strategic decision-making, research and development leadership, and administrative functions for Merial's worldwide animal health business.
The Lyon Gerland technology park, where Merial was located, is known as a major European hub for life sciences and biotechnology, likely featuring advanced laboratory and research facilities.
As a research-driven company, the culture likely emphasized scientific innovation, collaboration, a commitment to animal welfare, and a global mindset. It would have been a dynamic environment focused on developing and delivering solutions to veterinarians, farmers, and pet owners.
The Lyon headquarters was significant as it underscored Merial's French roots (through Rhône Mérieux) and its position as a major player in the global animal health industry, strategically located in a prominent European life sciences cluster.
Prior to its acquisition by Boehringer Ingelheim, Merial had a significant global presence, operating in more than 150 countries. This included R&D centers, manufacturing sites, and sales and marketing operations across North America, South America, Europe, Asia-Pacific, and Africa. Its functions supported veterinarians, livestock producers, and pet owners worldwide with a broad portfolio of vaccines, parasiticides, and therapeutic pharmaceuticals.
29 Avenue Tony Garnier
Lyon
Auvergne-Rhône-Alpes
France
Address: 3239 Satellite Blvd, Duluth, GA 30096, USA (historical address)
Key site for research, development, manufacturing, and commercial operations for the Americas region.
Address: Rodovia SP 135, Km 13,5 Bairro Tupi, Piracicaba, SP, Brazil (historical address)
Strategic location for serving the significant livestock market in Brazil and Latin America with tailored animal health solutions.
Address: Nanjing Economic and Technological Development Zone, Nanjing, China (general location)
Supported the growing animal health needs in Asia, particularly in the poultry sector, with local production.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Merial' leadership includes:
Merial has been backed by several prominent investors over the years, including:
Executive movements at Merial largely culminated with its acquisition by Boehringer Ingelheim in 2017. Post-acquisition, leadership was integrated into the Boehringer Ingelheim Animal Health structure. Specific hires/exits for Merial as an independent entity in its final 12 months are not readily available; most news focused on the transition.
Discover the tools Merial uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Historically, Merial likely used common corporate email formats. As Merial was acquired and integrated into Boehringer Ingelheim, these email formats are no longer active. Communications would now use Boehringer Ingelheim's email system.
Typically [first].[last]@merial.com or [first_initial][last]@merial.com
Format
jane.doe@merial.com
Example
0 (domain inactive or redirects)%
Success rate
Boehringer Ingelheim • January 2, 2017
Boehringer Ingelheim announced the successful closing of the business swap with Sanofi. As of January 1st 2017, Merial became part of Boehringer Ingelheim. This transaction strategically strengthens Boehringer Ingelheim's position as a global leader in animal health....more
Reuters • December 30, 2016
French drugmaker Sanofi and Germany's Boehringer Ingelheim finalized a $25 billion asset swap, with Sanofi exchanging its Merial animal health business for Boehringer's consumer healthcare unit....more
Veterinary Practice News • July 27, 2016
Merial Canada Inc. launched NexGard, a beef-flavored chewable for the treatment and control of fleas and ticks in dogs and puppies 8 weeks of age and older....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Merial, are just a search away.